Trotti, A., Colevas, A. D., Setser, A., & Basch, E. (2007). Patient-reported outcomes and the evolution of adverse event reporting in oncology. Journal of Clinical Oncology, 25(32), 5121–5127.
Article
PubMed
Google Scholar
Di, M. M., Gallo, C., Leighl, N. B., Piccirillo, M. C., Daniele, G., Nuzzo, F., et al. (2015). Symptomatic toxicities experienced during anticancer treatment: Agreement between patient and physician reporting in three randomized trials. Journal of Clinical Oncology, 33(8), 910–915.
Article
Google Scholar
Basch, E., Iasonos, A., McDonough, T., Barz, A., Culkin, A., Kris, M. G., et al. (2006). Patient versus clinician symptom reporting using the National Cancer Institute common terminology criteria for adverse events: Results of a questionnaire-based study. The Lancet Oncology, 7(11), 903–909.
Article
PubMed
Google Scholar
Basch, E., Reeve, B. B., Mitchell, S. A., Clauser, S. B., Minasian, L. M., Dueck, A. C., et al. (2014). Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Journal of the National Cancer Institute, 106(9).
Basch, E., Deal, A. M., Dueck, A. C., Scher, H. I., Kris, M. G., Hudis, C., et al. (2017). Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA.
Basch, E., Deal, A. M., Kris, M. G., Scher, H. I., Hudis, C. A., Sabbatini, P., et al. (2016). Symptom monitoring with patient-reported outcomes during routine cancer treatment: A randomized controlled trial. Journal of Clinical Oncology, 34(6), 557–565.
Article
CAS
PubMed
Google Scholar
Berry, D. L., Hong, F., Halpenny, B., Partridge, A. H., Fann, J. R., Wolpin, S., et al. (2014). Electronic self-report assessment for cancer and self-care support: Results of a multicenter randomized trial. Journal of Clinical Oncology, 32(3), 199–205.
Article
PubMed
Google Scholar
Denis, F., Yossi, S., Septans, A. L., Charron, A., Voog, E., Dupuis, O., et al. (2017). Improving survival in patients treated for a lung cancer using self-evaluated symptoms reported through a web application. American Journal of Clinical Oncology.
Denis, F., Lethrosne, C., Pourel, N., Molinier, O., Pointreau, Y., Domont, J., et al. (2017). Randomized trial comparing a web-mediated follow-up with routine surveillance in lung cancer patients. Journal of the National Cancer Institute, 109(9).
US Food and Drug Administration: Guidance for Industry on Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims; Availability 2009. [Available from: https://www.federalregister.gov/documents/2009/12/09/E9-29273/guidance-for-industry-on-patient-reported-outcome-measures-use-in-medical-product-development-to]. Accessed 1 Feb 2019.
Nissen, A., Bager, L., & Pappot, H. (2019). The use of PRO in adverse event identification during cancer therapy - choosing the right questions to ask. Acta oncologica (Stockholm, Sweden), 1–7.
Guancial, E. A., Roussel, B., Bergsma, D. P., Bylund, K. C., Sahasrabudhe, D., Messing, E., et al. (2015). Bladder cancer in the elderly patient: Challenges and solutions. Clinical Interventions in Aging, 10, 939–949 PMC4467651.
CAS
PubMed
PubMed Central
Google Scholar
Scosyrev, E., Wu, G., Golijanin, D., & Messing, E. (2013). Non-bladder cancer mortality in patients with urothelial cancer of the bladder. Urologic Oncology, 31(5), 656–663.
Article
PubMed
Google Scholar
Meeks, J. J., Bellmunt, J., Bochner, B. H., Clarke, N. W., Daneshmand, S., Galsky, M. D., et al. (2012). A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer. European Urology, 62(3), 523–533.
Article
CAS
PubMed
Google Scholar
Niegisch, G., Lorch, A., Droller, M. J., Lavery, H. J., Stensland, K. D., & Albers, P. (2013). Neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: Which patients benefit? European Urology, 64(3), 355–357.
Article
PubMed
Google Scholar
Kaufman, D. S., Shipley, W. U., & Feldman, A. S. (2009). Bladder cancer. Lancet, 374(9685), 239–249.
Article
CAS
PubMed
Google Scholar
Taarnhoej GA, Lindberg H, Johansen C, Pappot H. Patient-reported outcomes and quality of life in bladder cancer patients receiving chemotherapy; a real-life experience. Under review in Scientific Reports. 2019.
Rosenberg, J. E., Hoffman-Censits, J., Powles, T., van der Heijden, M. S., Balar, A. V., Necchi, A., et al. (2016). Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: A single-arm, multicentre, phase 2 trial. Lancet., 387(10031), 1909–1920.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bellmunt, J., de Wit, R., Vaughn, D. J., Fradet, Y., Lee, J. L., Fong, L., et al. (2017). Pembrolizumab as second-line therapy for advanced urothelial carcinoma. The New England Journal of Medicine, 376(11), 1015-26.PMC5635424.
Article
Google Scholar
Trask, P. C., Dueck, A. C., Piault, E., & Campbell, A. (2018). Patient-reported outcomes version of the common terminology criteria for adverse events: Methods for item selection in industry-sponsored oncology clinical trials. Clinical Trials (London, England), 15(6), 616–623.
Article
Google Scholar
Schmidt, H., Merkel, D., Koehler, M., Flechtner, H. H., Sigle, J., Klinge, B., et al. (2016). PRO-ONKO-selection of patient-reported outcome assessments for the clinical use in cancer patients-a mixed-method multicenter cross-sectional exploratory study. Support Care Cancer, 24(6), 2503–2512.
Article
PubMed
Google Scholar
Nordan, L., Blanchfield, L., Niazi, S., Sattar, J., Coakes, C. E., Uitti, R., et al. (2018). Implementing electronic patient-reported outcomes measurements: Challenges and success factors. BMJ Quality and Safety, 27(10), 852–856.
Article
PubMed
Google Scholar
Taarnhoj, G. A., Johansen, C., & Pappot, H. (2019). Quality of life in bladder cancer patients receiving medical oncological treatment; a systematic review of the literature. Health and Quality of Life Outcomes, 17(1), 20.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hasson, F., Keeney, S., & McKenna, H. (2000). Research guidelines for the Delphi survey technique. Journal of Advanced Nursing, 32(4), 1008–1015.
CAS
PubMed
Google Scholar
Christensen, A. I., Ekholm, O., Gray, L., Glümer, C., & Juel, K. (2015). What is wrong with non-respondents? Alcohol-, drug- and smoking-related mortality and morbidity in a 12-year follow-up study of respondents and non-respondents in the Danish health and morbidity survey. Addiction., 110(9), 1505–1512.
Article
PubMed
PubMed Central
Google Scholar
Tolonen, H., Laatikainen, T., Helakorpi, S., Talala, K., Martelin, T., & Prattala, R. (2010). Marital status, educational level and household income explain part of the excess mortality of survey non-respondents. European Journal of Epidemiology, 25(2), 69–76.
Article
PubMed
Google Scholar
Une, H., Miyazaki, M., & Momose, Y. (2000). Comparison of mortality between respondents and non-respondents in a mail survey. Journal of Epidemiology, 10(3), 136–139.
Article
CAS
PubMed
Google Scholar